Collaborative efforts to improve prevention of malaria in pregnancy in Burkina Faso through use of IPTp-SP

Mathurin Dodo, Stanislas Paul Nebie, Ousmane Badolo, Thierry Ouedraogo, Rachel Waxman, Danielle Burke, William R. Brieger, and Elaine Roman of Jhpiego’s USAID sponsored Improving Malaria Care project based in Ouagadougou, Burkina Faso will be presenting a poster on improving intermittent treatment of malaria in pregnancy at the 65th annual meeting of the American Society of Tropical Medicine and Hygiene on Monday 14th November in Atlanta. Their Abstract follows:

Ensuring the inclusion of IPTp3 doses and higher in the national health information system enabled documentation of improved coverage

Ensuring the inclusion of IPTp3 doses and higher in the national health information system enabled documentation of improved coverage

Malaria remains the first cause of consultation (47%), hospitalization (62%) and death (31%) in health facilities in Burkina Faso (2014 Statistical Yearbook). Pregnant women are among the most vulnerable to malaria. Intermittent preventive treatment in pregnancy (IPTp) is a priority intervention in the Burkina Faso 2011-2015 National Malaria Strategic Plan. In 2012, IPTp2 was low across the country at 53%.

The President’s Malaria Initiative (PMI) supported the National Malaria Control Program (NMCP) in implementing the national malaria control strategic plans. IPTp was promoted through 3 strategies: advocacy and policy updates, capacity building, and behavior change communication. Malaria prevention and management guidelines and job aids updated stressed IPTp in line with WHO recommendations.

iptp-for-blog185 trainers were trained who in turn organized one-day briefings for over 1,300 healthcare providers from 1081 health facilities (61.3% of health facilities nationally) on the revised guidelines, which were distributed along with job aids. Health information system tools now reflect new IPTp guidance, and 190 district and regional level data managers were trained in their use.

208 community health workers were trained in sensitization and community mobilization around early ANC attendance. Over 3000 radio and TV spots were aired on 28 stations on the importance of IPTp.

iptpIn 21 project districts in 2013, IPTp2 and IPTp3 coverage rates based on ANC registration were 54% and 0%. Following the interventions, rates in these districts increased to 72% (IPTp2) and 23% (IPTp3) in 2014 compared to 63% and 8% in the other 42 districts.

These efforts have resulted in improvements in IPTp service delivery and reporting. Based on successes, training and guideline dissemination continued in 2015 across the country so that all health facilities received copies of the new guidelines and 82% of districts received training.

Kenya: Tackling stock-outs of medicines for intermittent preventive treatment of malaria in pregnancy

Augustine Ngindu of Jhpiego/MCSP Kenya shared with the Jhpiego Malaria Team at their pre-ASTMH 2016 Annual Meeting retreat the experience in Kenya of drug stock-outs and efforts to combat this.

dscn0339Kenya has experienced periods of Sulfadoxine-Pyrimethamine (SP) stock-outs thus threatening the coverage of intermittent preventive treatment to prevent malaria in pregnant women (IPTp). The situation has stabilized from March 2016 through efforts by Jhpiego and the USAID Maternal and Child Survival Program (MCSP) in collaboration with Kenyan health authorities and partners at national, county and facility levels.

Jhpiego’s key interventions focused at several levels. At the national level technical assistance was provided to relevant Ministry of Health (MOH) departments (e.g. malaria, reproductive health and community strategy). In particular the situation on the ground has been used for advocacy with decision makers and managers on prioritizing procurement of SP.

At the County level Jhpiego is building capacity of counties in provision of MIP services by developing clinical mentors. Again advocacy was carried out on prioritizing inclusion of budget itesp-stock-out-affects-iptp-coveragem for SP.

At the health facility level Jhpiego is strengthening the capacity of health facilities to provide MIP services. These activities include training of health care workers and monitoring their performance in terms of maintaining, ordering and redistribution of SP stocks. In addition Jhpiego worked with the MOH to establish malaria in pregnancy (MIP) service standards to enhance the provision of quality services in 336 facilities providing ANC services.

Then at the community level Jhpiego and partners promote MIP service utilization at community level by sensitizing pregnant women to start IPTp early in second trimester. Community health volunteers sensitize pregnant women to start IPTp early in second trimester. Hopefully increased demand will also pressure program managers to supply regular SP stocks.

Concerning the service standards, baseline data collected after immediately training found that 50% of facilities were maintaining SP stocks. A second assessment done during supportive supervision 3 months after training found 86% of facilities now met the standard. As a result of county level advocacy, redistribution of SP was done from over-stocked to under-stocked health facilities.

In conclusion, advocacy is a powerful tool in getting things done as evidenced by responses of County Directors of Health, national government and health development partners on prioritizing procurement of SP. This led to availability of adequate SP stocks to last the country up to 2019.

Urine Rapid Diagnostic Test for Malaria: Results Published

Results of testing the innovative Urine Rapid Diagnostic Test for Malaria developed by Fyodor Biotech have been published in the Journal of Clinical Microbiology. Authors from multiple collaborating institutions include Wellington A. Oyibo, Nnenna Ezeigwe, Godwin Ntadom, Oladipo O. Oladosu, Kaitlin Rainwater, Wendy O’Meara, Evaezi Okpokoro, and William Brieger. The abstract appears below.

fydor_0 Background: The need to expand malaria diagnosis alongside policy requirements for mandatory testing before treatment motivates exploration of non-invasive rapid diagnostic tests (RDTs). We report the outcome of the first cross-sectional, single-blind clinical performance evaluation of a Urine Malaria Test (UMT) for Plasmodium falciparum (Pf) malaria diagnosis in febrile patients.

Methods: Matched urine and fingerprick blood from participants ?2 years with fever (axillary temperature ?37.5°C) or history of fever in the preceding 48 hours were tested with UMT and microscopy (as gold standard). BinaxNOW® (Pf/Pan) blood RDT was done to assess relative performance. Urinalysis and Rheumatoid Factor (RF) tests were conducted to evaluate possible interference. Diagnostic performance characteristics were computed at 95% CI.

UNT is winner of innovations prize

UMT is winner of innovations prize

Results: Of 1,800 participants screened, 1,691 were enrolled; 566 (34%) were febrile, 1,125 (66%) afebrile; test positivity among enrolled participants: 341 (20%) by microscopy, 419 (25%) UMT, 676 (40%) BinaxNow Pf and 368 (22%) BinaxNow Pan. UMT sensitivity among febrile patients (for whom the test is indicated) was 85% and specificity 84%. Among febrile children ?5 years, UMT sensitivity was 93%, specificity 83%. Area under receiver-operator characteristic curve (AUC) of UMT (0.84) was not significantly different from Binax Pf (0.86) or Binax Pan (0.87), indicating that the tests do not differ in overall performance. Gender, seasons, and RF did not impact UMT performance. Leukocytes, hematuria and urobilinogen concentration in urine were associated with lower UMT specificity.

Conclusion: UMT performance was comparable to BinaxNOW Pf/Pan tests, and is a promising tool to expand malaria testing in public and private healthcare settings where there are challenges to blood-based malaria diagnosis testing.

Malaria Excerpts from WHO’s New Antenatal Care Recommendations

new-who-anc-recommendations-2016Many years ago WHO formulated guidance for encouraging 4 Focused Antenatal Care (FANC) that addressed the reality that 1) ANC attendance schedules were not standardized, 2) service package elements were not clearly laid out, and 3) women found it difficult to attend ANC as many times as some countries recommended. The New York Times reported that WHO now recommends 8 ANC visits in large part because greater action is needed in light of the fact that …

“About 300,000 women die in pregnancy or childbirth each year, the agency said, and more than six million babies die in the womb, during birth or within their first month. Many of those deaths can by prevented through simple interventions.”

The new recommendations number 49 and strongly consider the roles of all health workers from auxiliaries to doctors – stressing task shifting to ensure that women have access to life saving services.  Below are extracted some of the aspects that relate to malaria.

  • In areas with endemic infections that may cause anaemia through blood loss, increased red cell destruction or decreased red cell production, such as malaria and hookworm, measures to prevent, diagnose and treat these infections should be implemented.
  • Malaria prevention: intermittent preventive treatment in pregnancy (IPTp): In malaria-endemic areas in Africa, intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) is recommended for all pregnant women. Dosing should start in the second trimester, and doses should be given at least one month apart, with the objective of ensuring that at least three doses are received.

The above recommendation has been, “Integrated from the WHO publication Guidelines for the treatment of malaria (2015), which also states: ‘WHO recommends that, in areas of moderate-to-high malaria transmission of Africa, IPTp-SP be given to all pregnant women at each scheduled ANC visit, starting as early as possible in the second trimester, provided that the doses of SP are given at least 1 month apart. WHO recommends a package of
interventions for preventing malaria during pregnancy, which includes promotion and use of insecticide-treated nets, as well as IPTp-SP’. To ensure that pregnant women in endemic areas start IPTp-SP as early as possible in the second trimester, policy-makers should ensure health system contact with women at 13 weeks of gestation.”

  • anc-attendance-4-countriesTask shifting components of antenatal care delivery: Task shifting the distribution of  recommended nutritional supplements and intermittent preventive treatment in  pregnancy (IPTp) for malaria prevention to a broad range of cadres, including auxiliary
    nurses, nurses, midwives and doctors is recommended.

Readers should download the full set of recommendations for more details on the above. We do offer a challenge. Since the 4-visit FANC processes, that was adopted in part because of the difficulty in getting pregnant women to attend ANC many times, is still not fully achieved (see graph), we must now strengthen community involvement, mobilization and education to double that target to 8 visits. Efforts must focus on women, men, elders and even youth. Health workers also need education and motivation to adopt a client-friendly attitude to make this new schedule work.

Ebola and the Irony of Bush Meat

The deadly Ebola epidemic of 2013-15 in West Africa was suspected of having started when a child in a remote village of Guinea came in contact with infected bats. After that initial episode NONE of the thousands of subsequent cases were traced to zoonotic causes, and yet the health authorities and the media put high level focus on the need to avoid bush meat – whether bats, monkeys, antelope or others – as a prime way to avoid the disease.

dos-and-donts-ebola-poster-final-07jul14_amhNew evidence is emerging that in fact it the evolving relationship between the virus and humans that allowed the disease to spread so widely. within the animal kingdon, humans, not bush meat where the major spreaders of Ebola.

Now two conflicting reports have surfaced about efforts to curb the consumption of bush meat.  First, a research team based in Rivers State, Nigeria, one of the places where Ebola reached, conducted a study that tracked the average number of carcases recorded in each market before and after the Ebola virus spread in Nigeria in June 2014. They reported that …

“The markets were surveyed twice a month between March and September 2014. Our survey found a statistically significant fall in trade for all the main traded types of animals. These included antelopes, monkeys, genets, mongooses, rodents, porcupines, birds, crocodiles, turtles and snakes. In particular, the trade in monkeys and fruit bats almost disappeared. Trade in turtles, crocodiles and other cold-blooded species was less affected.”

The group concluded that bush meat, though culturally valued, was “not as important as previously thought for rural people in west Africa.”

83ebb85e-bc1e-11e3-_562888c-getty-imagesThe second report, published a few days later, was posted in the Nigerian newspaper, Vanguard, and echos earlier stories.  ”

“Some bush meat sellers in some major markets in Lagos have said the business is booming again barely two years after the country was declared Ebola Virus Disease free. Some of the bush meat sellers told newsmen on Saturday that they were fully back to their business.”

Behavior change is not a simple process, especially when it comes to culturally rooted practices. Had better hygiene practices been possible by health workers and the public, it is possible that Ebola would have remained isolated. We should worry more about guaranteeing health workers the skills and equipment needed for infection prevention that the sales of bush meat.

Malaria work of Jhpiego to be featured at ASTMH 65th Meeting

jhpiego-logo-from-slideThe malaria work of Jhpiego will be featured in 8 posters and two symposia during the upcoming 65th annual meeting of the American Society of Tropical Medicine and Hygiene in Atlanta from 13-17 November 2016. Below are titles of the posters and descriptions of the symposia along with session information that will help people find the presenters. We will share abstracts closer to the actual time of presentation. Follow the conference on twitter through #TropMed16.


Poster Presentations

  1. Collaborative efforts to improve prevention of malaria in pregnancy in Burkina mip-bfFaso through use of IPTp-SP. Mathurin Dodo, Stanislas Paul Nebie, Ousmane Badolo, Thierry Ouedraogo Presentation No. 304 Poster Session A
  2. The Improving Malaria Care (IMC) Project’s Contribution to follow up a Pilot to Use Rapid Diagnostic Tests (RDTs) at the Community Level in Burkina Faso. Ousmane Badolo, Stanislas P. Nebie, Moumouni Bonkoungou, Mathurin Dodo, Rachel Waxman, Danielle Burke, William Brieger Presentation No. 218 Poster Session A
  3. Building Capacity to accelerate IPTp uptake through the adoption of 2012 WHO IPTp guidance in Malawi. John Munthali Presentation No. 393 Poster Session A
  4. Rwanda Towards Malaria Pre-Elimination: Active case investigation in a low endemic district. Noella Umulisa, Angelique Mugirente, Veneranda Umubyeyi, Beata Mukarugwiro, Stephen Mutwiwa, Jean Pierre Habimana, Corrine Karema Presentation No. 310 Poster Session A
  5. The Challenge of Reducing Malaria in Angola. Jhony Juarez, Margarita Gurdian-Sandoval, Julio Bonillo, William R. Brieger Presentation No. LB-5113 Poster Session A
  6. Joint efforts, a key to success for the Malaria in Pregnancy Program in Luanda, Angola. Jhony Juarez, Adolfo Sampaio, William R. Brieger, and Domingos F. Gueve Presentation No. 982 Poster Session B
  7. Improving pregnancy outcomes: Alleviating stock-outs situation of sulfadoxine pyrimethamine in Bungoma, Kenya. Augustine M. Ngindu, Gathari G. Ndirangu, Waqo Ejersa, David O. Omoit, Mildred Mudany Presentation No. 815 Poster Session B
  8. Community health: Improving start of IPTp early in second trimester through promotion of MIP at the community level in Kenya. Augustine Ngindu Presentation No. LB-5383 Poster Session C


  1. Global Call to Action to Increase Coverage of Intermittent Preventive Treatment in Pregnancy: Progress and Lessons Learned. Symposium 87 Tuesday, November 15, 2016  1:45 PM /  3:30 PM Sponsors: PMI and MCS

Description: The aim of the symposium is to review country progress in sub-Saharan Africa (SSA) in increasing intermittent preventative treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP).  The symposium will expand the knowledge base among Ministries of Health, donors and partners who are working to increase IPTp-SP coverage to address malaria in pregnancy (MiP). In this symposium, speakers from WHO and the President’s Malaria Initiative will describe how they are prioritizing support to scale up MiP interventions including IPTp-SP across SSA.  Burkina Faso, Malawi and Tanzania will present and discuss how they were able to dramatically scale up IPTp-SP through a health systems approach that addresses MiP from community to district to national level.

  1. Malaria Pre-Elimination: Ensuring Correct Care of Reproductive Age Women. Symposium 146 Wednesday, November 16, 2016 1:45 PM /  3:30 PM

Description: This symposium will present experiences from four countries – Mozambique, Sierra Leone, Brazil, and Dominican Republic; specifically, looking at how these countries have addressed pregnant women in their malaria pre-elimination strategies. Further the symposium will discuss the important ethical considerations that should be reviewed as countries contemplate standard diagnosis, notification and treatment vs. MDA. The lessons learned shared can be disseminated to guide other countries where these strategies are being considered.

Community health workers provide integrated community case management using malaria rapid diagnostic test kits

Please find below the abstract of the above named article that is first appearing as an accepted paper in the journal Research in Social and Administrative Pharmacy. The authors – Bright C. Orji, Namratha Rao, Elizabeth Thompson, William R. Brieger, Emmanuel
‘Dipo Otolorin – conducted this work as part of Jhpiego’s commitment to fighting malaria in Nigeria.


Background: Throughout Nigeria malaria is an endemic disease. Efforts to treat malaria can also be combined with other illnesses including pneumonia and diarrhea, which are killing children under five years of age. The use of Rapid Diagnostic Test (RDT) aids early  diagnosis of malaria and informs when other illnesses should be considered. Those with positive RDT results should be treated with Artemisinin-based Combination Therapy (ACTs), while those with negative RDTs results are further investigated for pneumonia and diarrhea.

Community Directed Distributor performs malaria rapid diagnostic test of febrile child

Community Directed Distributor performs malaria rapid diagnostic test of febrile child

Critical health systems challenges such as human resource constraints mean that community case management (CCM) and community health workers such as volunteers called Community Directed Distributors (CDDs) can therefore play an important role in diagnosing and treating malaria. This report described an effort to monitor and document the performance of trained CDDs in providing quality management of febrile illnesses including the use of RDTs.

Method: The program trained one hundred and fifty-two (152) CDDs on the use of RDTs to test for malaria and give ACTs for positive RDTs results, cotrimoxazole for the treatment of pneumonia and Oral rehydration solution and zinc for diarrhea They were also taught to counsel on compliance medicine, identify adverse reactions, and keep accurate records. The CDDs worked for 12 Calendar months. Their registers were retrieved and audited using a checklist to document client complaints, tests done, test results and treatment provided. No client identifying information was collected.

Results: There were 32 (21%) male CDDs and 120 (79%) females. The overall mean age of the CDDs was 36.8 (±8.7) years old. 89% of the male CDDs provided correct treatment based on RDT results compared to 97.6% of the female CDDs, a statistically significant difference. Likewise CDDs younger than 36 years of age provided 92.7% correct case management compared to those 36 years and older (98.4%). The difference between the age groups was also significant. There was a strong association between CDDs dispensing ACTs with positive RDT results. In RDT negative cases, the most common course of action was dispensing antibiotics (43.2%), followed by referring the patients (30.34%) and the providing ORS (24.1%).

Conclusion: Volunteer CDDs who are community members can adhere to treatment protocols and guidelines and comply with performance standards. The next step is scaling this approach to a state-wide level.

Accepted Date: 26 September 2016. Please cite this article as: Orji BC, Rao N, Thompson E, Brieger WR, ‘Dipo Otolorin E, Community health workers provide integrated community case management using malaria rapid diagnostic test kits, Research in Social & Administrative Pharmacy (2016), doi: 10.1016/j.sapharm.2016.09.006.

Malaria Day in The Americas Forum

In commemoration of Malaria Day in the Americas 2016

The Pan American Health Organization, The UN Foundation, The Milken Institute School of Public Health at The George Washington University, and Center for Communication Programs at The Johns Hopkins Bloomberg School of Public Health

Cordially invite you to attend the

“End Malaria for Good” Forum

Featuring videos, presentations and discussions on

The work of the ‘Malaria Champions of the Americas 2016’

malariaevite-2016-americasWHEN: Thursday, November 3, 2016, TIME: 1:00 p.m. to 3:30 p.m.

WHERE: Room B, PAHO Headquarters, 525 23rd Street NW, Washington, DC—20037

RSVP: Please fill out the form at

Light refreshments will be served

Malaria, Lymphatic Filariasis and Insecticide-treated Nets



Throughout Africa one of the main vectors that carry Lymphatic Filariasis (LF) is the Anopheles mosquito, which also carries the malaria parasite. The Carter Center has been promoting use of insecticide treated nets (ITNs) for many years as part of its LF control efforts, but others may not have gotten the message.

The global community is targeting LF for elimination in 2020. The primary strategy is mass drug administration annually with ivermectin and albendazole. The plan is that up to seven annual rounds of drug distribution in endemic communities where 90% of population coverage is achieved is necessary to stop LF transmission. The Carter Center explains that distribution of long-lasting insecticidal bed nets (LLINs) protects pregnant women and children who cannot take drug treatment.

The LF strategy often builds on and integrates with onchocerciasis control efforts where these diseases overlap. The community directed treatment with ivermectin (CDTI) model pioneered by the African Program for Onchocerciasis Control  (APOC), wherein communities or villages plan together the distribution process including selecting their own community directed distributors (CDDs). This model has also been used to distribute ITNs.

20160818_100110-1A second component of the LF strategy is morbidity management which focuses on enhanced personal hygiene or cleaning of the parts of the body that experience lymphedema. Another aspect uses surgery to address some of the worst effects, hydrocele.  While this component does not ‘control’ LF, it is a necessary effort to reduce suffering and the negative stigma from the disease.

To judge whether transmission has stopped and elimination has been achieved Transmission Assessment Surveys (TAS) are conducted with rapid diagnostic tests on young children after at least 5 years of MDA in a community.  Specifically WHO recommends an implementation unit must have completed five effective rounds of annual MDA defined as achieving rates of drug coverage exceeding 65% in the total population.

For example the Carter Center in Support of the Nigerian Federal Ministry of Health worked in Plateau and Nasarawa States through community health education, delivery of long lasting insecticide-treated nets (LLINs) and 33 million drug treatments for lymphatic filariasis and river blindness between 2000 and 2011. “In 2012, it was confirmed (through TAS) that lymphatic filariasis transmission had stopped. Post-treatment surveillance is currently underway to assure that the parasite is not reintroduced into the area.”

Another component of the assessment process is yet to be fully realized. That is the testing of mosquitoes for the presence of microfilariae. This indirectly implies an important role in preventing human-vector contact as would be achieved through the use of ITNs as well as indoor residual spray (IRS).

Vector control can benefit more than one disease. Integrated vector management is seen as a key tool to prevent reintroduction of LF in areas where anopheles mosquitoes carry the disease and where ITN campaigns are successful.

Ultimately the key to benefiting from the disease control synergies provided by insecticide-treated nets is an understanding what if any effect nets have on transmission. This poses a challenge in terms of separating it from the effect of MDAs as well as the fact that MDAs are time-limited. As MDAs are still underway in many places it is incumbent on program managers to monitor and evaluate the impact of all activities, treatment and vector control, over the next decade to determine the success of eliminating LF and hopefully malaria, too.

Malaria, Onchocerciasis and Ivermectin – Possibility of Eliminating Two Diseases

Many tropical diseases are co-endemic in a given country and environment. Therefore, it only makes sense to learn whether there can be common strategies and synergies in disease control and elimination efforts. Onchocerciasis or River Blindness is carried by the black fly (simulium damnosum) that breeds along the banks of fast flowing rivers and malaria are examples.

Onchocerciasis was eliminated in many settings in the Sahel through the process or aerial spraying of these riverbanks to kill the black fly larvae. Though the insecticide used was often the same as used for malaria larviciding, the habitats differed and no synergies were achieved then.


Merck donates ivermectin to achieve control and elimination of onchocerciasis

Through subsequent programs using community directed treatment with ivermectin (Mectizan ®) interventions sponsored by the African Program for Onchocerciasis Control (APOC) it was learned that ivermectin also had beneficial effects on malaria transmission.

Ivermectin had been used in agriculture not only for internal parasites of animals. The agricultural community has long known that ivermectin kills both internal parasites (worms) but is also effective against some external parasites (lice and ticks).

Around 2010 scientists began to consider the anti-mosquito effects ivermectin might have when humans consumed it. It turns out that after a mass distribution in a community of ivermectin for onchocerciasis that mosquitoes feeding on people who had recently swallowed ivermectin would die. This was demonstrated when mosquitoes bit volunteers who took ivermectin of the first few days after consumption died there was no effect in the group not taking the drug.


Ivermectin distribution sessions in a Cameroonian village

Of particular interest was the fact that people who had consumed ivermectin would contribute to mosquito mortality even when they were outdoors. While the effect was not long lasting, the onchocerciasis control programs in the Americas have shown that it is safe to administer the drug two or four times a year.

Research that looks at the malaria parasite concluded that, “it is likely that ivermectin treatment is arresting parasite growth.” The researchers note that, “given the prior use of ivermectin and its safety record in humans and animals, it can be considered in combination therapy with other antimalarials.” The issue of dosage would need to be tested further.  Ivermectin at sub-lethal concentrations even inhibits the sporogony of P. falciparum in An. Gambiae.

Because of the need to find new and complementary tools to eliminate malaria the Malaria Policy Advisory Committee (MPAC) of the World Health Organization’s Global Malaria Program considered at its recent meeting the role of endectocides including ivermectin in the future of malaria control and elimination and the importance of further research.

The future of malaria elimination requires finding new tools to integrate with and the strengthening of existing tools. If these efforts also benefit the control and elimination of other diseases, the public’s health will benefit.